Recent outcomes from the MAVERIC clinical trial confirm earlier positive findings that MVRx’s Arto System safely and effectively treats mitral valve regurgitation associated with congestive heart failure. The results, presented by leading cardiologists at EuroPCR 2017, May 16-19 in Paris, France, offer heart patients the promise of a less-invasive treatment for a life-threatening problem that affects more than 5 million people worldwide.
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative ...
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Strain Fundamentals ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
At the 2017 annual meeting of the Society for Imaging Informatics in Medicine (SIIM), June 1-3 in Pittsburgh, Konica Minolta Healthcare Americas Inc. will showcase advanced specialty viewing capabilities of the Exa Enterprise Imaging platform. The platform facilitates the viewing of large medical imaging files, such as cardiac imaging and nuclear medicine, quickly and efficiently on existing workstations throughout the enterprise. With the Exa diagnostic quality Zero Footprint Universal Viewer, clinicians can view these images and more from any modality and any vendor. Exa delivers relevant priors from the picture archiving and communication system (PACS) or vendor neutral archive (VNA), including cardiovascular images, quickly and securely.
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancements ...
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day reduction in ICU stay and a $3,654 reduction in per-patient hospitalization costs for coronary artery bypass graft (CABG) surgery. The reported outcomes, which included no severe hypoglycemia less than 40 mg/dL, were derived from an intensive glycemic control protocol supported by Glytec’s Glucommander for personalized insulin dosing.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 25, 2017 — A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast ...
May 25, 2017 — Positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program ...
The May/June digital edition of Diagnostic and Interventional Cardiology (DAIC) is now available at http:/ ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Fourteen members of the Society of Interventional Radiology (SIR) took to Capitol Hill recently to express the society’s support for a bill that would expand access to government-funded graduate medical education (GME) opportunities to newly recognized primary specialties, including interventional radiology.
May 24, 2017 — Late-breaking data presented at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter ...
May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces the risk of ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
W. L. Gore & Associates (Gore) announced positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech Republic. Gore plans to submit the positive data to the U.S. Food and Drug Administration (FDA) to seek a PFO indication for the Gore Cardioform Septal Occluder by year-end 2017.
May 24, 2017 — Philips recently announced the results from a global study indicating that automated three-dimensional ...
Death in patients with heart failure is inversely related to the wealth of the country they live in, according to late breaking results from the INTERCHF study presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France. Death rates in India and Africa were three to four times higher than those documented in Western countries.